Interleukin 6 (IL6), tumor necrosis factor α (TNFα) and TNF receptor-1(TNFR1) have been shown to involve in oval cell proliferation and hepatocellular carcinoma (HCC) development. However, their role in these processes is still unclear. In the present study, by using hepatocytes-specific DDB1 deletion mouse models, we explored the role and mechanism of IL6, TNFα and TNFR1 in oval cell proliferation and HCC development in the context of inflammation, which is the common features of HCC pathogenesis in humans. Our results showed that IL6 promotes oval cell proliferation and liver regeneration, while TNFα/TNFR1 does not affect this process. 
INTRODUCTION
Cytokines modulate various cell types in the liver. Among them, interleukine-6 (IL6) and tumor necrosis factor α (TNFα), which are produced mainly by macrophage, may be the most critical ones [1] . They are implicated in both liver physiological and pathological processes, including regeneration and hepatocellular carcinoma (HCC) [2, 3] .
Under liver pathological conditions, liver progenitor cells or oval cells, which have bi-potential capacity to differentiate into hepatocytes and cholangiocytes, are activated to restore liver mass [4] . TNFα and IL6 are suggested to promote oval cell proliferation in this process [5, 6] . However, due to incapable of distinguishing newborn hepatocytes from pre-exist ones, liver regeneration could not be fully assessed in these chemical injury models [7] . Furthermore, recent studies found that oval cells play minor if any contribution to liver regeneration in conventional chemicals injury models, including thionine-supplemented(CDE) and 3-diethoxycarbonyl-1,4-dihydrocollidine (DDC) [8] . Therefore, the roles of TNFα and IL6 in oval cellsmediated liver regeneration are required to be re-evaluated in an appropriate model, in which oval cells contribute a lot to liver regeneration.
In addition to liver regeneration, IL6 and TNFa/TNFR1 signaling pathways are also involved Research Paper in HCC development [9] . Deletion of IL6 inhibited diethylnitrosamine(DEN)-induced HCC development in mouse [10] . TNFα and TNFR1 do not contribute to HCC development induced by DEN, but promote obesity-and long-term CDE-induced HCC development [11, 12] . Thus, IL6 and TNFα/TNFR1 signaling pathways promote HCC development in most mouse models. However, HCC patients with high level of IL6 and TNFα have better prognosis [13] [14] [15] . 90% of HCC cases in human arised in the context of hepatic inflammation [16] , while in chemicals induced HCC models, tumors arise from chemically induced mutation without initial underlying hepatitis [17] . Therefore, re-evaluating the role of IL6, TNFα and TNFR1 in mouse model whose HCC development is accompanied with inflammation is more appropriately.
To re-evaluate the role of cytokines in oval cellsmediated liver regeneration and HCC development in inflammatory condition, we explored IL6 and TNFα/ TNFR1 signaling in genetic induced hepatocyte damage model. Hepatocyte-specific deletion of damaged-binding protein 1(DDB1), an adaptor protein for Cullin4 ubiquitin ligase, blocks the proliferation ability of hepatocytes, resulting in compensatory regeneration mediated by oval cells and progressive tumor development in the context of inflammation [18] . Newborn hepatocytes derived from oval cells could be genetically distinguished in our model, and oval cells were induced independent of chemicals excluding the promiscuous effects of chemicals [7] . In addition, persistent deletion of DDB1 in DDB1 F/F ,Alb-Cre +/− mouse results in HCC arises in aged mice, preceding by intra-hepatic inflammation and immune cells infiltration [18] . Herein, by using hepatocyte-specific DDB1 knockout models, we reported divergent roles of IL6, TNFα and TNFR1 in oval cellsmediated liver regeneration and inflammation-associated hepatocarcinogenesis. We previously reported that injection of poly(I:C) into DDB1 F/F ,Mx1-Cre +/− mouse induced hepatocytespecific DDB1 deletion. Oval cells are activated and differentiated into DDB1 positive hepatocytes subsequently [18] . Expression of IL6 was upregulated in the liver of DDB1 Figure 1D, 1E −/− mouse ( Figure 2A ). Restricted proliferation of oval cells was further confirmed by significant reduction of CK19 and Thy1 ( Figure 2B ). Furthermore, upregulation of HGF and TWEAK, two important factors for oval cell proliferation, was significantly attenuated by IL6 deletion( Figure 2C ). Collectively, these results suggested that IL6 is required for oval cell proliferation, partly by promoting the expression of HGF and TWEAK. Figure 3A-3C ). The expression of TNFα was also not varied significantly after poly(I:C) injection, as shown in Figure 3D . These results suggested that TNFα/TNFR1-mediated signaling pathway was dispensable for oval cell proliferation and liver regeneration in DDB1 Figure 4A , by IHC for biomarkers of leukocytes(CD45) and macrophage (F4/80), more inflammatory cells in 12 months old DDB1 F/F ,Alb-Cre +/− mouse than age-matched control were observed, while no difference of inflammatory cells between DEN-treated and age-match control. We also evaluated the level of inflammation when noticeable HCC developed by IHC and RT-PCR. As shown Figure  4B and C, more inflammatory cells infiltration and T/B cells were detected in DDB1 Figure S1) . At age of 21 months, even the tumor incidence was similar, the maximum tumor size increased significantly in DDB1
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IL6 deficiency delayed liver generation in
F/F ,Mx1-Cre +/− mouse.
Intra-hepatic inflammation and immune cells infiltration before tumors arise in DDB1
IL6 suppresses HCC in
-/-mouse ( Figure 5A , 5B). Although Liver injury was elevated by deletion of IL6 reflected in ALT measurement, the apoptosis and compensatory proliferation was unaltered with similar level of cleavedcaspase3 and PCNA in IL6 wildtype and deficient DDB1 Figure 9 ). Taken together, our results suggested that TNFR1 elevated HCC incidence, partially by promoting cells turnover and upregulating P-ERK. Unlike TNFR1, deletion of TNFα accelerated HCC development, which showed divergent role of TNFα and TNFR1 in hepatocarcinogenesis.
DISCUSSION
The involvement of IL6, TNFα and TNFR1 in oval cells mediated liver regeneration and HCC development has been explored by numerous studies with controversial results and discrepancy between experimental and clinical data [13, 20, 21] . By using hepatocyte-specific DDB1 deletion mouse models, we found IL6 promotes oval cells-mediated liver regeneration, while TNFα/ TNFR1 signaling pathway does not affect this process. Intriguingly, TNFα and TNFR1showed divergent role in inflammation-associated hepatocarcinogenesis, and for the first time, the anti-tumor function of IL6 in HCC was revealed in present study.
Recently, Lu et al. reported that deletion of Mdm2, an E3 ubiquitin ligase responsible for P53 degradation, in hepatocytes resulted in P53 accumulation and elicited cell death and senescence. Subsequently, oval cells were induced and differentiated into P53 negative hepatocytes to restore liver mass [22] . Similarly, hepatocyte-specific deletion of DDB1 mouse is characterized by replenishment of DDB1 negative hepatocytes with positive ones. Distinct from chemicals injury models, oval cells are the major source of newborn hepatocytes, and liver regeneration could be genetically assessed [7, 18] . Therefore, DDB1
F/F , Mx1-Cre +/− mouse model suits the investigation for oval cells mediated liver regeneration.
During hepatocytes reconstitution, elevated expression of IL6 was detected, which may secreted by inflammatory cells or senescent hepatocytes [23] . IL6 is shown to promote liver regeneration after partial hepatectomy [24] and oval cell proliferation induced by CDE diet [5] . Therefore, we speculated that IL6 is required for oval cells-mediated liver regeneration in DDB1 mouse. This hypothesis was confirmed by IL6 depletion, which showed delayed liver regeneration and restricted oval cell proliferation. Previous studies have suggested IL6 promotes oval cell proliferation by activating JAK/STAT3 signaling [5] . Consistently, activation of JAK/STAT3 was observed in DDB1 liver injury, compensatory proliferation, and intrahepatic inflammation was not aggravated in DDB1
−/− mouse. Interestingly, NK cells were decreased significantly in tumors without IL6. NK cells play an important role in tumor surveillance, it exerts antitumor function by direct cytotoxicity or cytokine secretion such as IFNγ [27] . In HCC patients, high density of intratumoral NK cells correlated with long survival rate [28] . To date, the relationship between NK cells and IL6 is still unclear and controversial [29] [30] [31] . Based on our results, we postulated that IL6 signaling modulates NK cells to inhibiting inflammation-associated hepatocarcinogenesis, the underlying mechanism will be our next step.
Differ from IL6, TNFR1 depletion reduced HCC incidence in DDB1 F/F ,Alb-Cre +/− mouse, accompanied with decreased cell death/compensatory proliferation and inhibited activation of MAPK/MEK/ERK cascade. The oncogenic function of TNFR1 may mediate through cell death/compensatory proliferation and MAPK/MEK/ ERK cascade, due to the positive correlation between them and hepatocarcinogenesis [32] [33] [34] . Although TNFR1 signaling is mainly initiated by TNFα, which is suggested to promote HCC development in mdr2 −/− mouse [35] , deletion of TNFα accelerated rather than inhibited hepatocarcinogenesis in DDB1 F/F ,Alb-Cre +/− mouse. The divergent role of TNFα and TNFR1 implies that other ligands bind TNFR1 to promote HCC development, probably lymphotoxin-α, whose overexpression with lymphotoxin-β elicited HCC spontaneously [36] .
Taken together, by using hepatocyte-specific DDB1 deletion mouse models, the roles of IL6 and TNFα/TNFR1 signaling in liver regeneration and hepatocarcinogenesis were systematically investigated. IL6 promotes liver regeneration by stimulating oval cell proliferation, while TNFα/TNFR1 signaling is dispensable for this process. For the first time, the antitumor role of IL6 in hepatocarcinogenesis was suggested, and NK cells were shown to involve in. Although TNFR1 promotes HCC development in DDB1 
Experimental protocol
For deletion of DDB1 in DDB1 −/− mice, 6-8 weeks mice were i.p. injected polyinosinic:polycytidylic acid (poly(I:C) (GE healthcare) at 13 mg/kg mouse weight. For DEN model, DEN (sigma) was injected intraperitoneally into 2 weeks old male mice at a dose of 25 mg/kg mouse weight. For BrdU incorporation assays, mice were injected intraperitoneally with 100 mg/kg BrdU and sacrificed 1 h later.
Western blot analysis
Liver tissues were homogenized in RIPA buffer (sigma) containing protease inhibitor cocktail (Roche), incubated on ice for 30 min, and centrifuged for 15 min at 12,000 g, 4°C. Protein concentration was quantified by BCA protein kit (Thermo). Equal amounts of protein were separated discontinuously on 4-12% SDS-PAGE gel and transferred to polyvinylidene difluoride membrane (Millipore). The membranes were incubated overnight at 4°C with the desired primary antibodies, washed three times with TBS/T and incubated with the appropriate HRP-conjugated secondary antibodies (Santa Cruz) for 1 hour at room temperature. Protein level was detected by chemiluminescence (Pierce Biotechnology). The antibodies used for Western blotting include: anti-p44/42 MAPK (Erk1/2) (Thr202/Tyr204), anti-p44/42 MAPK (Erk1/2), anti-β-catenin, anti-P-STAT3(Thr705) and anti-STAT3(Cell Signaling Technology), anti-PCNA, antip53(Santa Cruz), anti-DDB1 and anti-β-actin(Abcam).
Immunohistochemistry and immunofluorescence
Five-micrometer paraffin tissue sections were prepared. After blocking endogenous peroxidase activity and non-specific staining, the sections were incubated overnight at 4°C with the primary antibodies. Immunohistochemistry (IHC) was done using the streptavidin-biotin peroxidase complex method according to manufacturer's instructions (Lab Vision). For immunofluorescence (IF), slides were incubated with DAPI for 3 minutes after incubating with fluoresceinconjugated primary antibodies, washed with PBS and then covered with anti-fade(Sangon Biotech). Antibodies used for immunohistochemistry were: anti-CD45 and anti-F4/80(eBioscience), anti-EpCAM (Abcam), anti-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (Cell Signaling Technology), biotin conjugated anti-BrdU (Millipore), anti-cleaved-caspase3 (Cell signaling Technology) and anti-DDB1 (Bethyl Laboratories). PE-Cy7 conjugated anti-NK1.1 (eBioscience) was used for immunofluorescence.
Real Time-PCR (RT-PCR)
Total RNA was purified from liver tissue samples using Trizol (Invitrogen) according to manufacturer's protocol. Reverse transcript was performed using PrimeScript RT Master Mix kit (Takara). Real time PCR was carried out in SYBR Green PCR Master Mix (Bio-Rad) with ABI PRISM 7500 Sequence Detection System. Primer sequences are listed in Supplementary Table S1 . Each measurement was performed in triplicate and results were normalized to the expression of gapdh reference gene.
Serum alanine transaminases assay
Blood collected from mice incubated in room temperature for 2 hours, then centrifuge at 2000 g for 20 minutes. Serum in the upper layer after centrifuge transferred to new tubes. The activity of alanine www.impactjournals.com/oncotarget transaminase (ALT) in serum was measured by alanine transaminases assay kit (Nanjin jiancheng).
Statistical analysis
Data were analyzed using SPSS and represented as the mean ± SEM. Comparisons between two groups were performed using an unpaired Student's t-test. P < 0.05 was considered statistically significant
